Symbols / NEO $8.29 +0.62%
NEO Chart
About
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 1.08B |
| Enterprise Value | 1.32B | Income | -108.03M | Sales | 727.33M |
| Book/sh | 6.49 | Cash/sh | 1.23 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2500 | IPO | — |
| P/E | — | Forward P/E | 25.98 | PEG | — |
| P/S | 1.48 | P/B | 1.28 | P/C | — |
| EV/EBITDA | -724.60 | EV/Sales | 1.81 | Quick Ratio | 3.61 |
| Current Ratio | 4.26 | Debt/Eq | 48.95 | LT Debt/Eq | — |
| EPS (ttm) | -0.84 | EPS next Y | 0.32 | EPS Growth | — |
| Revenue Growth | 10.60% | Earnings | 2026-04-28 | ROA | -2.90% |
| ROE | -12.43% | ROIC | — | Gross Margin | 43.16% |
| Oper. Margin | -6.56% | Profit Margin | -14.85% | Shs Outstand | 129.81M |
| Shs Float | 119.30M | Short Float | 8.96% | Short Ratio | 4.57 |
| Short Interest | — | 52W High | 13.74 | 52W Low | 4.72 |
| Beta | 1.64 | Avg Volume | 1.91M | Volume | 449.55K |
| Target Price | $14.81 | Recom | Buy | Prev Close | $8.24 |
| Price | $8.29 | Change | 0.62% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$14.81
Mean price target
2. Current target
$8.27
Latest analyst target
3. DCF / Fair value
$2.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.27
Low
$13.00
High
$17.00
Mean
$14.81
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | main | Piper Sandler | Overweight → Overweight | $13 |
| 2026-02-17 | main | Needham | Buy → Buy | $15 |
| 2026-01-12 | reit | Needham | Buy → Buy | $14 |
| 2025-09-12 | main | TD Cowen | Buy → Buy | $12 |
| 2025-09-02 | main | Stephens & Co. | Overweight → Overweight | $11 |
| 2025-08-29 | main | Needham | Buy → Buy | $14 |
| 2025-08-04 | main | Piper Sandler | Overweight → Overweight | $11 |
| 2025-07-30 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $8 |
| 2025-07-29 | down | William Blair | Outperform → Market Perform | — |
| 2025-07-29 | main | Needham | Buy → Buy | $8 |
| 2025-05-06 | main | Piper Sandler | Overweight → Overweight | $12 |
| 2025-05-01 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $10 |
| 2025-04-30 | main | Goldman Sachs | Buy → Buy | $10 |
| 2025-04-30 | down | Leerink Partners | Outperform → Market Perform | $9 |
| 2025-04-29 | main | Needham | Buy → Buy | $9 |
| 2025-04-17 | main | Goldman Sachs | Buy → Buy | $15 |
| 2025-02-26 | main | Piper Sandler | Overweight → Overweight | $18 |
| 2025-02-19 | main | B of A Securities | Neutral → Neutral | $16 |
| 2025-02-19 | main | Needham | Buy → Buy | $18 |
| 2025-01-28 | main | Goldman Sachs | Buy → Buy | $18 |
News
RSS: Latest NEO news- CoreWeave Just Landed a Deal With Perplexity. Why This Neocloud Stock Could Be the Comeback Play of 2026. - The Motley Fool ue, 17 Mar 2026 18
- NeoGenomics, Inc. $NEO Stock Position Increased by First Light Asset Management LLC - MarketBeat Mon, 16 Mar 2026 10
- Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - simplywall.st ue, 17 Mar 2026 08
- Medicare to cover NeoGenomics blood test profiling over 500 genes - Stock Titan Mon, 16 Mar 2026 11
- (NEO) Investment Report (NEO:CA) - Stock Traders Daily ue, 17 Mar 2026 00
- NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - StockStory Mon, 16 Mar 2026 20
- Apple’s Budget MacBook Is a Hit. What It Means For the Stock, and What’s Next. - Barron's ue, 10 Mar 2026 18
- Every MacBook Neo color is available at retail, shipping delays increase - AppleInsider Wed, 11 Mar 2026 21
- Issuance/retirement of stock (net) of Canasil Resources Inc. – NEO:CLZ - TradingView ue, 17 Mar 2026 00
- As Analysts Praise the New MacBook Neo as a Game-Changer, Should You Buy Apple Stock? - Yahoo Finance hu, 12 Mar 2026 19
- Parallels shares update on MacBook Neo and running a Windows virtual machine - 9to5Mac hu, 12 Mar 2026 15
- NeoGenomics (NASDAQ:NEO) Stock Price Down 7.9% - Should You Sell? - MarketBeat hu, 12 Mar 2026 17
- Tokyo’s Ginza gets VIP-focused NEO Skin Clinic for global aesthetic tourists - Stock Titan Mon, 16 Mar 2026 12
- Neo Performance Materials Inc. (NOPMF) Stock Jumps 12.9%: Will It Continue to Soar? - Yahoo Finance Wed, 25 Feb 2026 08
- CRM Stock Price and Chart — NEO:CRM - TradingView Sat, 14 Mar 2026 16
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 29522 | — | — | OLIVO ALICIA C | General Counsel | — | 2026-02-23 00:00:00 | D | nan |
| 1 | 36548 | — | — | STONE WARREN | President | — | 2026-02-23 00:00:00 | D | nan |
| 2 | 57693 | — | — | SHERMAN JEFFREY SCOTT | Chief Financial Officer | — | 2026-02-23 00:00:00 | D | nan |
| 3 | 6323 | — | — | AUNAN GREGORY D | Officer | — | 2026-02-20 00:00:00 | D | nan |
| 4 | 22128 | — | Sale at price 12.50 per share. | STONE WARREN | President | — | 2026-01-20 00:00:00 | D | 276682.0 |
| 5 | 59382 | — | — | OLIVO ALICIA C | General Counsel | — | 2026-01-13 00:00:00 | D | nan |
| 6 | 59382 | — | — | STONE WARREN | President | — | 2026-01-13 00:00:00 | D | nan |
| 7 | 20916 | — | Sale at price 12.00 per share. | OLIVO ALICIA C | General Counsel | — | 2025-11-25 00:00:00 | D | 250992.0 |
| 8 | 8977 | — | Conversion of Exercise of derivative security at price 10.05 per share. | OLIVO ALICIA C | General Counsel | — | 2025-11-25 00:00:00 | D | 90219.0 |
| 9 | 4918 | — | Sale at price 10.00 per share. | OLIVO ALICIA C | Officer | — | 2025-10-16 00:00:00 | D | 49180.0 |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -563.39K | -161.12K | -1.04M | -427.21K |
| TaxRateForCalcs | 0.02 | 0.02 | 0.09 | 0.09 |
| NormalizedEBITDA | -10.94M | 5.15M | -6.52M | -77.81M |
| TotalUnusualItems | -27.75M | -6.66M | -11.09M | -4.52M |
| TotalUnusualItemsExcludingGoodwill | -27.75M | -6.66M | -11.09M | -4.52M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -108.03M | -78.73M | -87.97M | -144.25M |
| ReconciledDepreciation | 67.82M | 72.55M | 72.58M | 69.43M |
| ReconciledCostOfRevenue | 378.91M | 331.81M | 308.44M | 285.17M |
| EBITDA | -38.69M | -1.51M | -17.61M | -82.33M |
| EBIT | -106.52M | -74.06M | -90.19M | -151.76M |
| NetInterestIncome | 5.32M | 11.81M | 9.99M | -1.51M |
| InterestExpense | 3.75M | 6.62M | 6.91M | 7.58M |
| InterestIncome | 9.07M | 18.43M | 16.90M | 6.08M |
| NormalizedIncome | -80.84M | -72.23M | -77.92M | -140.16M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -108.03M | -78.73M | -87.97M | -144.25M |
| TotalExpenses | 815.46M | 746.01M | 688.29M | 662.84M |
| TotalOperatingIncomeAsReported | -115.88M | -92.11M | -107.74M | -157.62M |
| DilutedAverageShares | 128.10M | 126.66M | 125.50M | 124.22M |
| BasicAverageShares | 128.10M | 126.66M | 125.50M | 124.22M |
| DilutedEPS | -0.84 | -0.62 | -0.70 | -1.16 |
| BasicEPS | -0.84 | -0.62 | -0.70 | -1.16 |
| DilutedNIAvailtoComStockholders | -108.03M | -78.73M | -87.97M | -144.25M |
| NetIncomeCommonStockholders | -108.03M | -78.73M | -87.97M | -144.25M |
| NetIncome | -108.03M | -78.73M | -87.97M | -144.25M |
| NetIncomeIncludingNoncontrollingInterests | -108.03M | -78.73M | -87.97M | -144.25M |
| NetIncomeContinuousOperations | -108.03M | -78.73M | -87.97M | -144.25M |
| TaxProvision | -2.24M | -1.95M | -9.13M | -15.09M |
| PretaxIncome | -110.27M | -80.67M | -97.10M | -159.34M |
| OtherIncomeExpense | -27.46M | -7.04M | -10.44M | -4.73M |
| OtherNonOperatingIncomeExpenses | 296.00K | -379.00K | 644.00K | -213.00K |
| SpecialIncomeCharges | -27.75M | -6.66M | -11.09M | -4.52M |
| ImpairmentOfCapitalAssets | 27.75M | 0.00 | 0.00 | |
| RestructuringAndMergernAcquisition | 0.00 | 6.66M | 11.09M | 4.52M |
| EarningsFromEquityInterest | 0.00 | 0.00 | 109.26M | |
| NetNonOperatingInterestIncomeExpense | 5.32M | 11.81M | 9.99M | -1.51M |
| InterestExpenseNonOperating | 3.75M | 6.62M | 6.91M | 7.58M |
| InterestIncomeNonOperating | 9.07M | 18.43M | 16.90M | 6.08M |
| OperatingIncome | -88.13M | -85.45M | -96.65M | -153.11M |
| OperatingExpense | 402.42M | 375.55M | 341.25M | 341.00M |
| DepreciationAmortizationDepletionIncomeStatement | 33.69M | 33.90M | 33.98M | 32.77M |
| DepreciationAndAmortizationInIncomeStatement | 33.69M | 33.90M | 33.98M | 32.77M |
| Amortization | 12.80M | 13.81M | 15.49M | 14.65M |
| AmortizationOfIntangiblesIncomeStatement | 12.80M | 13.81M | 15.49M | 14.65M |
| DepreciationIncomeStatement | 20.89M | 20.09M | 18.49M | 18.12M |
| ResearchAndDevelopment | 37.08M | 31.16M | 27.31M | 30.33M |
| SellingGeneralAndAdministration | 331.65M | 310.49M | 279.96M | 277.91M |
| SellingAndMarketingExpense | 91.92M | 84.62M | 70.84M | 67.32M |
| GeneralAndAdministrativeExpense | 239.74M | 225.87M | 209.12M | 210.59M |
| OtherGandA | 239.74M | 225.87M | 209.12M | 210.59M |
| GrossProfit | 314.29M | 290.10M | 244.60M | 187.90M |
| CostOfRevenue | 413.04M | 370.47M | 347.04M | 321.83M |
| TotalRevenue | 727.33M | 660.57M | 591.64M | 509.73M |
| OperatingRevenue | 727.33M | 660.57M | 591.64M | 509.73M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 128.99M | 128.15M | 127.37M | 126.91M |
| ShareIssued | 128.99M | 128.15M | 127.37M | 126.91M |
| NetDebt | 182.24M | 174.10M | 195.71M | 272.14M |
| TotalDebt | 409.46M | 605.33M | 611.68M | 610.93M |
| TangibleBookValue | 25.69M | 39.89M | 45.64M | 67.00M |
| InvestedCapital | 1.18B | 1.44B | 1.48B | 1.53B |
| WorkingCapital | 287.99M | 294.78M | 500.51M | 515.36M |
| NetTangibleAssets | 25.69M | 39.89M | 45.64M | 67.00M |
| CapitalLeaseObligations | 67.60M | 64.22M | 73.48M | 75.61M |
| CommonStockEquity | 836.56M | 902.34M | 941.54M | 998.02M |
| TotalCapitalization | 1.18B | 1.24B | 1.48B | 1.53B |
| TotalEquityGrossMinorityInterest | 836.56M | 902.34M | 941.54M | 998.02M |
| StockholdersEquity | 836.56M | 902.34M | 941.54M | 998.02M |
| GainsLossesNotAffectingRetainedEarnings | 4.00K | -206.00K | -1.67M | -3.90M |
| OtherEquityAdjustments | 4.00K | -206.00K | -1.67M | -3.90M |
| RetainedEarnings | -433.81M | -325.78M | -247.06M | -159.09M |
| AdditionalPaidInCapital | 1.27B | 1.23B | 1.19B | 1.16B |
| CapitalStock | 129.00K | 128.00K | 127.00K | 127.00K |
| CommonStock | 129.00K | 128.00K | 127.00K | 127.00K |
| TotalLiabilitiesNetMinorityInterest | 523.27M | 735.70M | 739.69M | 742.01M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 434.97M | 434.46M | 643.39M | 652.08M |
| OtherNonCurrentLiabilities | 12.07M | 11.77M | 13.03M | 13.05M |
| NonCurrentDeferredLiabilities | 18.22M | 21.51M | 24.29M | 34.75M |
| NonCurrentDeferredTaxesLiabilities | 18.22M | 21.51M | 24.29M | 34.75M |
| LongTermDebtAndCapitalLeaseObligation | 404.68M | 401.18M | 606.07M | 604.27M |
| LongTermCapitalLeaseObligation | 62.82M | 60.84M | 67.87M | 68.95M |
| LongTermDebt | 341.86M | 340.33M | 538.20M | 535.32M |
| CurrentLiabilities | 88.30M | 301.24M | 96.30M | 89.93M |
| CurrentDeferredLiabilities | 851.00K | 409.00K | 2.13M | 7.56M |
| CurrentDeferredRevenue | 851.00K | 409.00K | 2.13M | 7.56M |
| CurrentDebtAndCapitalLeaseObligation | 4.78M | 204.16M | 5.61M | 6.65M |
| CurrentCapitalLeaseObligation | 4.78M | 3.38M | 5.61M | 6.65M |
| CurrentDebt | 200.78M | |||
| OtherCurrentBorrowings | 200.78M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 47.58M | 62.44M | 53.16M | 40.14M |
| PayablesAndAccruedExpenses | 35.09M | 34.23M | 35.40M | 35.58M |
| CurrentAccruedExpenses | 12.00M | 12.62M | 15.07M | 15.07M |
| Payables | 23.09M | 21.61M | 20.33M | 20.51M |
| AccountsPayable | 23.09M | 21.61M | 20.33M | 20.51M |
| TotalAssets | 1.36B | 1.64B | 1.68B | 1.74B |
| TotalNonCurrentAssets | 983.54M | 1.04B | 1.08B | 1.13B |
| OtherNonCurrentAssets | 9.39M | 5.89M | 4.74M | 5.11M |
| InvestmentsAndAdvances | 0.00 | |||
| LongTermEquityInvestment | 0.00 | |||
| InvestmentsinAssociatesatCost | 0.00 | |||
| GoodwillAndOtherIntangibleAssets | 810.87M | 862.45M | 895.89M | 931.03M |
| OtherIntangibleAssets | 286.53M | 339.68M | 373.13M | 408.26M |
| Goodwill | 524.34M | 522.77M | 522.77M | 522.77M |
| NetPPE | 163.28M | 173.69M | 183.78M | 198.61M |
| AccumulatedDepreciation | -209.06M | -189.99M | -158.21M | -131.93M |
| GrossPPE | 372.33M | 363.68M | 341.99M | 330.54M |
| Leases | 59.41M | 57.57M | 49.23M | 44.42M |
| ConstructionInProgress | 7.73M | 8.51M | 3.61M | 8.98M |
| OtherProperties | 182.69M | 180.92M | 190.33M | 187.87M |
| MachineryFurnitureEquipment | 122.51M | 116.67M | 98.82M | 89.27M |
| BuildingsAndImprovements | 0.00 | |||
| LandAndImprovements | 0.00 | |||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 376.29M | 596.02M | 596.81M | 605.29M |
| OtherCurrentAssets | 7.42M | 11.72M | 8.24M | 8.08M |
| AssetsHeldForSaleCurrent | 0.00 | 10.05M | ||
| PrepaidAssets | 21.44M | 20.16M | 17.99M | 15.24M |
| Inventory | 28.57M | 26.75M | 24.16M | 24.28M |
| Receivables | 159.24M | 150.54M | 131.23M | 119.71M |
| AccountsReceivable | 159.24M | 150.54M | 131.23M | 119.71M |
| CashCashEquivalentsAndShortTermInvestments | 159.62M | 386.84M | 415.20M | 437.99M |
| OtherShortTermInvestments | 0.00 | 19.83M | 72.72M | 174.81M |
| CashAndCashEquivalents | 159.62M | 367.01M | 342.49M | 263.18M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -21.78M | -34.04M | -30.70M | -96.88M |
| RepaymentOfDebt | -201.25M | 0.00 | 0.00 | 0.00 |
| IssuanceOfDebt | 0.00 | 0.00 | 334.41M | |
| IssuanceOfCapitalStock | 962.00K | 4.65M | 4.62M | 12.59M |
| CapitalExpenditure | -27.01M | -41.06M | -28.75M | -30.89M |
| InterestPaidSupplementalData | 1.69M | 3.83M | 3.38M | 3.40M |
| IncomeTaxPaidSupplementalData | 515.00K | 207.00K | 175.00K | 180.00K |
| EndCashPosition | 159.62M | 367.01M | 342.49M | 263.18M |
| BeginningCashPosition | 367.01M | 342.49M | 263.18M | 316.83M |
| ChangesInCash | -207.39M | 24.52M | 79.31M | -53.65M |
| FinancingCashFlow | -200.29M | 4.65M | 4.55M | 11.83M |
| CashFlowFromContinuingFinancingActivities | -200.29M | 4.65M | 4.55M | 11.83M |
| NetOtherFinancingCharges | -70.00K | -758.00K | -32.34M | |
| NetCommonStockIssuance | 962.00K | 4.65M | 4.62M | 12.59M |
| CommonStockIssuance | 962.00K | 4.65M | 4.62M | 12.59M |
| NetIssuancePaymentsOfDebt | -201.25M | 0.00 | 0.00 | 0.00 |
| NetLongTermDebtIssuance | -201.25M | 0.00 | 0.00 | 0.00 |
| LongTermDebtPayments | -201.25M | 0.00 | 0.00 | 0.00 |
| LongTermDebtIssuance | 0.00 | 0.00 | 334.41M | |
| InvestingCashFlow | -12.34M | 12.86M | 76.71M | 517.00K |
| CashFlowFromContinuingInvestingActivities | -12.34M | 12.86M | 76.71M | 517.00K |
| NetOtherInvestingChanges | 1.57M | 12.10M | -15.00M | |
| NetInvestmentPurchaseAndSale | 19.56M | 53.92M | 105.46M | 19.31M |
| SaleOfInvestment | 20.06M | 53.92M | 112.22M | 116.92M |
| PurchaseOfInvestment | -500.00K | 0.00 | -6.76M | -97.61M |
| NetBusinessPurchaseAndSale | -6.45M | 0.00 | 0.00 | 0.00 |
| PurchaseOfBusiness | -6.45M | 0.00 | 0.00 | 0.00 |
| NetPPEPurchaseAndSale | -27.01M | -41.06M | -28.75M | -30.89M |
| PurchaseOfPPE | -27.01M | -41.06M | -28.75M | -30.89M |
| OperatingCashFlow | 5.23M | 7.02M | -1.95M | -65.99M |
| CashFlowFromContinuingOperatingActivities | 5.23M | 7.02M | -1.95M | -65.99M |
| ChangeInWorkingCapital | -32.09M | -32.63M | -25.49M | -31.70M |
| ChangeInOtherWorkingCapital | -3.36M | -3.07M | -11.19M | -16.10M |
| ChangeInOtherCurrentLiabilities | -2.21M | -6.00M | -7.62M | -8.56M |
| ChangeInOtherCurrentAssets | -8.56M | -7.88M | ||
| ChangeInPayablesAndAccruedExpense | -20.36M | 5.28M | 8.47M | 2.79M |
| ChangeInAccruedExpense | -15.66M | 9.28M | 13.02M | 1.84M |
| ChangeInPayable | -4.69M | -4.00M | -4.55M | 958.00K |
| ChangeInAccountPayable | -4.69M | -4.00M | -4.55M | 958.00K |
| ChangeInPrepaidAssets | 1.55M | -6.83M | -3.18M | -1.16M |
| ChangeInInventory | -1.54M | -2.70M | -454.00K | -1.10M |
| ChangeInReceivables | -6.18M | -19.31M | -11.52M | -7.58M |
| ChangesInAccountReceivables | -6.18M | -19.31M | -11.52M | -7.58M |
| OtherNonCashItems | 8.43M | 12.02M | 12.30M | 14.33M |
| StockBasedCompensation | 41.32M | 33.41M | 24.63M | 24.67M |
| AssetImpairmentCharge | 27.75M | 450.00K | 1.70M | 718.00K |
| DepreciationAmortizationDepletion | 67.82M | 72.55M | 72.58M | 69.43M |
| DepreciationAndAmortization | 67.82M | 72.55M | 72.58M | 69.43M |
| AmortizationCashFlow | 31.75M | 33.45M | 35.13M | 34.06M |
| AmortizationOfIntangibles | 31.75M | 33.45M | 35.13M | 34.06M |
| Depreciation | 36.07M | 39.10M | 37.45M | 35.37M |
| OperatingGainsLosses | 31.00K | -49.00K | 292.00K | 810.00K |
| EarningsLossesFromEquityInvestments | 0.00 | 0.00 | -109.26M | |
| NetIncomeFromContinuingOperations | -108.03M | -78.73M | -87.97M | -144.25M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NEO
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|